Ziopharm Oncology Company Profile (NASDAQ:ZIOP)

About Ziopharm Oncology

ZIOPHARM Oncology, Inc. is a biopharmaceutical company. The Company is seeking to acquire, develop and commercialize, on its own or with partners, a portfolio of cancer therapies through synthetic immuno-oncology. Its clinical-stage product candidate, Ad-RTS-IL-12, is used with the oral activator veledimex. The Company's Ad-RTS-IL-12 + veledimex has been evaluated in two Phase II studies, the first for the treatment of metastatic melanoma, and the second for the treatment of unresectable recurrent or metastatic breast cancer. It has initiated the Phase I study for malignant glioma. The Company has completed the Phase II monotherapy studies in melanoma and breast cancer using Ad-RTS-IL-12 + veledimex. It has initiated a Phase Ib/II study of Ad-RTS-hIL-12 + veledimex following chemotherapy for the treatment of patients with locally metastatic breast cancer. Its initial drug candidate being developed using the synthetic immuno-oncology platform is Ad-RTS-IL-12 + veledimex.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: ZIOP
• CUSIP: 98973P10

Key Metrics:

• Previous Close: $5.48
• 50 Day Moving Average: $5.47
• 200 Day Moving Average: $6.43
• 52-Week Range: $4.45 - $14.93
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -12.40
• P/E Growth: 0.00
• Market Cap: $771.23M
• Outstanding Shares: 130,496,000
• Beta: 1.63

Profitability:

• Net Margins: -2,292.26%
• Return on Equity: -100.01%
• Return on Assets: -34.70%

Debt:

• Current Ratio: 7.90%
• Quick Ratio: 7.90%

Additional Links:

• Visit Ziopharm Oncology's Official Website
• View ZIOP on Google Finance
• View ZIOP on Yahoo Finance
• View ZIOP's Company Profile on Reuters
• Search for Ziopharm Oncology Inc. on Google

Companies Related to Ziopharm Oncology:

• Myriad Genetics (NASDAQ:MYGN)
• Axovant Sciences (NYSE:AXON)
• Cambrex Corp. (NYSE:CBM)
• Five Prime Therapeutics (NASDAQ:FPRX)
• Acceleron Pharma (NASDAQ:XLRN)
• Accelerate Diagnostics (NASDAQ:AXDX)
• Omnicell (NASDAQ:OMCL)
• Clovis Oncology (NASDAQ:CLVS)
• Magellan Health Services (NASDAQ:MGLN)
• TherapeuticsMD (NYSEMKT:TXMD)

Earnings

Earnings History for Ziopharm Oncology (NASDAQ:ZIOP)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
10/31/2016
8/9/2016	Q216	($0.11)	($1.01)	$1.52 million	$1.70 million	View	N/A
5/10/2016	Q1	($0.08)	($0.09)	$1.89 million	$1.97 million	View	N/A
2/24/2016	Q4	($0.07)	($0.07)			View	N/A
11/2/2015	Q315	($0.13)	($0.14)	$1.19 million	$1.90 million	View	N/A
8/10/2015	Q2	($0.22)	($0.11)			View	N/A
5/7/2015		($0.13)	($0.10)	$0.20 million	$0.30 million	View	N/A
2/26/2015	Q414	($0.14)	($0.09)	$420.00 million	$0.34 million	View	N/A
10/30/2014	Q314	($0.12)	($0.06)	$3.43 million		View	N/A
8/7/2014	Q214	($0.17)	($0.06)	$7.50 million	$0.20 million	View	N/A
5/8/2014	Q114	($0.10)	($0.10)	$0.20 million	$0.20 million	View	N/A
3/3/2014	Q413	($0.15)	($0.09)	$0.20 million	$0.20 million	View	N/A
10/22/2013	Q313	($0.17)	($0.20)		$0.20 million	View	N/A
8/8/2013	Q2 2013	($0.24)	($0.22)	$0.20 million	$0.20 million	View	N/A
3/18/2013	Q4 2012	($0.29)	($0.48)	$0.17 million	$0.20 million	View	N/A
11/8/2012	Q312	($0.28)	($0.28)	$0.20 million	$0.20 million	View	N/A
8/2/2012		($0.23)	($0.29)			View	N/A
5/3/2012		($0.22)	($0.25)			View	N/A
2/29/2012		($0.23)	($0.24)			View	N/A
11/3/2011		($0.28)	($0.01)			View	N/A
8/1/2011		($0.23)	($0.16)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ziopharm Oncology (NASDAQ:ZIOP)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.07)	($0.07)	($0.07)
Q2 2016	1	($0.12)	($0.12)	($0.12)
Q3 2016	1	($0.12)	($0.12)	($0.12)
Q4 2016	1	($0.11)	($0.11)	($0.11)
Q2 2017	1	($0.12)	($0.12)	($0.12)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ziopharm Oncology (NASDAQ:ZIOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ziopharm Oncology (NASDAQ:ZIOP)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
6/4/2015	Murray Brennan	Director	Sell	40,000	$9.70	$388,000.00
2/9/2015	Randal J Kirk	Director	Buy	1,440,000	$8.75	$12,600,000.00
10/29/2013	Randal J Kirk	Director	Buy	2,857,143	$3.50	$10,000,000.50

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ziopharm Oncology (NASDAQ:ZIOP)

Date	Headline
	2 Stocks Attracting Analyst Attention: KapStone Paper and ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 28 at 5:17 AM
	Active Biotech Stock News: Alexion Pharmaceuticals, Inc. (ALXN), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP) theindependentrepublic.com - September 28 at 5:17 AM
	2 Biotech Stocks News And Price Trends: ZIOPHARM Oncology, Inc. (UTC:ZIOP), Eleven Biotherapeutics, Inc ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 28 at 5:17 AM
	ETF’s with exposure to ZIOPHARM Oncology, Inc. : September 27, 2016 (NASDAQ:ZIOP) www.capitalcube.com - September 27 at 8:08 PM
	First Week of November 18th Options Trading For ZIOPHARM Oncology (ZIOP) (NASDAQ:ZIOP) www.stockoptionschannel.com - September 21 at 7:45 PM
	Biotech Stocks Worth a Closer Look: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 21 at 12:03 PM
	Biotech stocks for your portfolio: Celldex Therapeutics, Inc. (CLDX), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP) theindependentrepublic.com - September 20 at 8:34 AM
	Top Biotechnology Stock Picking: Celldex Therapeutics, Inc. (CLDX), ZIOPHARM Oncology, Inc. (ZIOP) - The Independent Republic (NASDAQ:ZIOP) theindependentrepublic.com - September 19 at 3:41 PM
	HC Stocks Impression! Aetna Inc (AET), ZIOPHARM Oncology Inc ... - share market updates (press release) (NASDAQ:ZIOP) sharemarketupdates.com - September 19 at 3:41 PM
	ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Cosumnes Connection (subscription) (NASDAQ:ZIOP) www.crcconnection.com - September 17 at 5:16 AM
	Quarterly Financial Review of ZIOPHARM Oncology Inc (NASDAQ ... - Newburg Press (NASDAQ:ZIOP) newburghpress.com - September 17 at 5:16 AM
	Analysts Valuations For Two Stocks: Investors Real Estate Trust (NYSE:IRET), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 14 at 8:29 PM
	ZIOP January 2019 Options Begin Trading - TheStreet.com (NASDAQ:ZIOP) www.thestreet.com - September 13 at 5:13 AM
	HC Stocks News Ring= Intrexon Corp (XON), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) - share market updates (press release) (NASDAQ:ZIOP) sharemarketupdates.com - September 13 at 5:13 AM
	ZIOPHARM Oncology, Inc. – Value Analysis (NASDAQ:ZIOP) : September 12, 2016 (NASDAQ:ZIOP) www.capitalcube.com - September 12 at 7:42 PM
	New Broker Ratings For ZIOPHARM Oncology Inc (ZIOP) - Cosumnes Connection (subscription) (NASDAQ:ZIOP) www.crcconnection.com - September 9 at 7:50 PM
	Hot Biotech Stocks Recap: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Halozyme Therapeutics, Inc. (NASDAQ:HALO) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 9 at 7:50 PM
	ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : September 9, 2016 (NASDAQ:ZIOP) www.capitalcube.com - September 9 at 7:50 PM
	Ziopharm put sale bets on end to slide (NASDAQ:ZIOP) finance.yahoo.com - September 9 at 7:50 PM
	Time To Put On The Watch List? - ZIOPHARM (ZIOP), CEL-SCI (CVM) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 9 at 5:25 AM
	Placing ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Shares Under the Microscope - National Daily Press (NASDAQ:ZIOP) www.nationaldailypress.com - September 9 at 5:25 AM
	Stock Struggling for the Quarter: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - Post News (NASDAQ:ZIOP) www.kentuckypostnews.com - September 4 at 5:24 AM
	HC Stocks Newsbeat - Skyline Medical Inc (NASDAQ:SKLN ... - share market updates (press release) (NASDAQ:ZIOP) sharemarketupdates.com - September 2 at 6:27 AM
	Trading the Biotech News: Celgene Corporation (NASDAQ:CELG), ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 2 at 6:27 AM
	Time To Put On The Watch List? – ZIOPHARM Oncology, Inc ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - September 2 at 6:27 AM
	ZIOPHARM to Present at the 2016 Wells Fargo Healthcare Conference (NASDAQ:ZIOP) finance.yahoo.com - September 1 at 11:38 AM
	Notable Stock's Buzzers: ZIOPHARM Oncology Inc.(NASDAQ:ZIOP ... - NYSE Journal (press release) (NASDAQ:ZIOP) stockznews.com - August 27 at 5:22 AM
	Mid-Afternoon Market Update: Guess? Jumps On Earnings Beat; Signet Jewelers Shares Tumble - Benzinga (NASDAQ:ZIOP) www.benzinga.com - August 25 at 8:39 PM
	Biotech Stocks To Put On Your Watch List: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - August 25 at 5:22 AM
	Analyst's keeping an Eye on: ZIOPHARM Oncology Inc (NASDAQ ... - Newburg Press (NASDAQ:ZIOP) newburghpress.com - August 23 at 8:32 PM
	ZIOPHARM Oncology, Inc.'s (ZIOP): Investor's Alert - Hot Stocks Point (NASDAQ:ZIOP) www.hotstockspoint.com - August 23 at 8:32 PM
	Intraday Active Biotech Stocks News: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Vertex Pharmaceuticals Incorporated ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - August 23 at 8:32 PM
	ZIOP April 2017 Options Begin Trading (NASDAQ:ZIOP) www.thestreet.com - August 22 at 8:22 PM
	ZIOPHARM ONCOLOGY INC Financials (NASDAQ:ZIOP) finance.yahoo.com - August 18 at 8:37 PM
	Can ZIOPHARM Oncology Inc (NASDAQ:ZIOP) Keep Up With Analyst Expectations? - Investor Newswire (NASDAQ:ZIOP) www.investornewswire.com - August 18 at 11:36 AM
	Notable Wednesday Option Activity: FDX, ZIOP, BAH (NASDAQ:ZIOP) www.marketnewsvideo.com - August 17 at 8:44 PM
	ZIOPHARM Oncology Inc. (NASDAQ:ZIOP): It’s All About Timing The Buy Action To Make Quick Money (NASDAQ:ZIOP) www.marketnewscall.com - August 17 at 11:24 AM
	Analysts Valuations For Two Stocks: ZIOPHARM Oncology Inc. (ZIOP), Bed Bath & Beyond Inc. (BBBY) - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - August 16 at 11:47 AM
	ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August 16, 2016 (NASDAQ:ZIOP) www.capitalcube.com - August 16 at 11:47 AM
	ZIOPHARM Oncology Inc. (NASDAQ:ZIOP): That’s How We Bought At $5.09 And Now Up 15% Already (NASDAQ:ZIOP) www.marketnewscall.com - August 15 at 8:44 PM
	ETF’s with exposure to ZIOPHARM Oncology, Inc. : August 15, 2016 (NASDAQ:ZIOP) www.capitalcube.com - August 15 at 8:44 PM
	Biotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), Sangamo Biosciences Inc ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - August 12 at 8:35 PM
	ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:ZIOP) www.capitalcube.com - August 12 at 8:35 PM
	Biotech news that matter for investors: ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP), ImmunoCellular Therapeutics, Ltd ... - The Voice Registrar (NASDAQ:ZIOP) voiceregistrar.com - August 11 at 9:04 PM
	ZIOPHARM upgraded by Wells Fargo (NASDAQ:ZIOP) finance.yahoo.com - August 10 at 9:11 PM
	Ziopharm Oncology (ZIOP) Stock Advances After Q2 Results, Upgrade (NASDAQ:ZIOP) www.thestreet.com - August 10 at 9:11 PM
	ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP) globenewswire.com - August 9 at 8:46 PM
	BRIEF-Ziopharm Q2 loss per share $1.01 (NASDAQ:ZIOP) www.reuters.com - August 9 at 8:45 PM
	ZIOPHARM Oncology Inc.: ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities (NASDAQ:ZIOP) www.twst.com - August 9 at 8:45 PM
	Ziopharm reports 2Q loss (NASDAQ:ZIOP) sg.finance.yahoo.com - August 9 at 8:45 PM

Social

Ziopharm Oncology (NASDAQ:ZIOP) Chart for Thursday, September, 29, 2016